Analytical Data
-
Gene name
DME
- Application
-
Alternative Names
DNA glycosylase-related protein DME
-
Species
Arabidopsis thaliana
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8LK56
-
Expression Region
1-320aa
-
Molecular Weight
51.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DME (Dopamine-Metabolizing Enzyme) recombinant proteins have emerged as a focal point of research in the context of neurobiology and psychiatric disorders, particularly due to their critical role in dopamine metabolism. Dopamine is a key neurotransmitter involved in various physiological functions, including mood regulation, motor control, and cognitive processes. Aberrations in dopamine metabolism have been linked to several neuropsychiatric conditions such as Parkinson's disease, schizophrenia, and drug addiction. The study of DME recombinant proteins allows researchers to better understand the enzymatic pathways involved in dopamine synthesis and degradation, facilitating insights into how dysregulation can lead to disease. Furthermore, these proteins can serve as valuable tools for drug development and therapeutic interventions, providing avenues for more effective treatments targeting dopamine-related disorders. By utilizing techniques such as gene cloning and protein expression systems, scientists can produce these recombinant enzymes in vitro, enabling detailed biochemical characterization and functional assays. Overall, the investigation of DME recombinant proteins not only enhances our understanding of dopamine's role in health and disease but also paves the way for innovative strategies in the management of neuropsychiatric disorders.
